Dr. Symmans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
NYU Grossman School of MedicineResidency, Immunopathology, 1993 - 1995
University of Texas M D Anderson Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1992 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
University of Auckland Faculty of Medicine and Health SciencesClass of 1986
Certifications & Licensure
TX State Medical License 2000 - 2025
NY State Medical License 1996 - 2003
PA State Medical License 1992 - 1996- American Board of Pathology Anatomic Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Smith, K., Zhao, F., Mayer, I., Tevaarwerk, A., Garcia, S., Arteaga, C., Symmans, W., Park, B., Burnette, B., Makower, D., Block, M., Morley, K., Jani, C., Mescher, C....> ;Cancer. 2024 Jan 18
- Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
- 1 citationsImmunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A Hoadley, Joel S Parker, Baljit Singh, Jordan D Campbell, Karla V Ballman, David W...> ;Nature Communications. 2023 Nov 3
- Join now to see all
Press Mentions
Residual Cancer Burden Predicts Outcomes for All Breast Cancer TypesFebruary 25th, 2020
Committees
- Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
